Nonepithelial Ovarian Cancer
Key points
- They include malignancies of germ cell origin, sex cord-stromal cell origin, metastatic carcinomas to the ovary, and a variety of extremely rare ovarian cancers, such as sarcomas and lipoid cell tumors (Figure 118-7).
- Nonepithelial malignancies account for about 10% of all ovarian cancers.
- Although there are many similarities in the presentation, evaluation, and management of these patients, there are also many unique qualities of these tumors that require a special approach.
- This is particularly true because many more nonepithelial lesions are germ cell in origin, and they are usually found in young patients.
Introduction
Nonepithelial cancers of the ovary are uncommon. They include malignancies of germ cell origin, sex cord-stromal cell origin, metastatic carcinomas to the ovary, and a variety of extremely rare ovarian cancers, such as sarcomas and lipoid cell tumors (Figure 118-7). Nonepithelial malignancies account for about 10% of all ovarian cancers. Although there are many similarities in the presentation, evaluation, and management of these patients, there are also many unique qualities of these tumors that require a special approach. This is particularly true because many more nonepithelial lesions are germ cell in origin, and they are usually found in young patients.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsResearch backs risk-reduction surgery for ovarian cancer
A study by Manchester scientists backs preventative surgery to improve survival for women who are at greater risk of getting ovarian cancer and suggests it appears helpful for women at risk of getting breast cancer…
18 December 2013
NewsSurviving Ovarian Cancer: Rutgers Scientists Attack Drug Resistant Cancer Cells
Scientists at Rutgers University have developed a targeted drug delivery system that they believe could make ovarian cancer more treatable and increase survival rates for the most deadly gynecological cancer in the…
10 December 2013
NewsNanotech system, cellular heating may improve treatment of ovarian cancer
The combination of heat, chemotherapeutic drugs and an innovative delivery system based on nanotechnology may significantly improve the treatment of ovarian cancer while reducing side effects from toxic drugs,…
